Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Reproductive Sciences
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Reis, F. M.
Right arrow Articles by Petraglia, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reis, F. M.
Right arrow Articles by Nascimento, L. L.
Right arrow Articles by Tsigkou, A.
Right arrow Articles by Ferreira, M. C.
Right arrow Articles by Luisi, S.
Right arrow Articles by Petraglia, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Activin A and Follistatin in Menstrual Blood: Low Concentrations in Women With Dysfunctional Uterine Bleeding

Fernando M. Reis, MD, PhD

Department of Obstetrics and Gynecology, University of Minas Gerais, Belo Horizonte, Brazil, Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena, Italy

Lívia L. Nascimento, MD

Department of Obstetrics and Gynecology, University of Minas Gerais, Belo Horizonte, Brazil

Anastasia Tsigkou, PhD

Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena, Italy

Márcia C. Ferreira, MD

Department of Obstetrics and Gynecology, University of Minas Gerais, Belo Horizonte, Brazil

Stefano Luisi, MD, PhD

Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena, Italy

Felice Petraglia, MD

Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena, Italy, petraglia{at}unisi.it

Activin A and follistatin are growth factors produced by several organs, comprising the endometrium, where they modulate cell and tissue differentiation. In this study, the authors tested whether activin A and follistatin are measurable in menstrual blood and whether their concentrations change in women with dysfunctional uterine bleeding (DUB). The authors evaluated healthy women with regular menstrual cycles (n = 15) and women with DUB (n = 12). Activin A and follistatin were measured in both menstrual and peripheral blood samples using highly sensitive enzyme immunoassays, whereas their respective mRNAs were quantified by real-time polymerase chain reaction in endometrial samples collected during the perimenstrual period. Activin A concentrations were 4-fold higher in menstrual than in peripheral serum of healthy women (mean ± SE, 4.24 ± 0.18 vs 1.00 ± 0.15 ng/mL, P < .001) and were significantly lower in women with DUB compared to healthy subjects (P < .001). Follistatin concentration was 8-fold higher in menstrual than in peripheral serum of healthy women (3.94 ± 0.49 vs 0.49 ± 0.04 ng/mL, P < .001) and was significantly lower in the menstrual serum of women with DUB compared to controls (P < .001). There was no correlation between menstrual and peripheral serum concentrations of both proteins. The endometrial expression of activin A and follistatin mRNA was lower in women with DUB compared to controls (P < .05). Both activin A and follistatin are measurable in high concentrations in human menstrual blood and are relatively lower in women with DUB. The quantitative assessment of activin A and follistatin in menstrual serum might be a putative clinical marker of endometrial function.

Key Words: Activin • follistatin • endometrium • menstruation.

Reproductive Sciences, Vol. 14, No. 4, 383-389 (2007)
DOI: 10.1177/1933719107303985


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
P. Florio, F.M. Reis, P.B. Torres, F. Calonaci, M.S. Abrao, L.L. Nascimento, M. Franchini, L. Cianferoni, and F. Petraglia
High serum follistatin levels in women with ovarian endometriosis
Hum. Reprod., October 1, 2009; 24(10): 2600 - 2606.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Kaitu'u-Lino, D. J. Phillips, N. B. Morison, and L. A. Salamonsen
A New Role for Activin in Endometrial Repair after Menses
Endocrinology, April 1, 2009; 150(4): 1904 - 1911.
[Abstract] [Full Text] [PDF]